Concepedia

Antonio Passaro

AP

Statistics

Publications

48

Citations

4.7K

H-Index

25

Active since

2013

Affiliations

European Institute of Oncology(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Sungkyunkwan University

Samsung Medical Center

Yonsei University

Antonio Passaro is an author at European Institute of Oncology specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2013–2025

48

Publications

48

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 790 citations · Full text

, , +14

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 624 citations · Full text

, , +3

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 580 citations · Full text

, , +14

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 396 citations · Full text

, , +17

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC

Byoung Chul Cho, Shun Lu, Enriqueta Felip et al. · New England Journal of Medicine · 2024 · 375 citations · Full text

, , +14

1–5 of 48